COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 629: Articles 6281-6290  | Next

Stability of SARS-CoV-2 in cold-chain transportation environments and the efficacy of disinfection measures
Peng, S., Li, G., Pathak, J. L., Guo, X., Lin, Y., Xu, H., Qiu, W., Zheng, J., Sun, W., Hu, X., Zhang, G., Li, B., Bi, X., Dai, J.
10.1101/2022.08.09.503429 — Posted: 2022-08-10
Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
Ren, P., Hu, Y., Peng, L., Yang, L., Suzuki, K., Fang, Z., Bai, M., Zhou, L., Feng, Y., Xiong, Y., Chen, S.
10.1101/2022.08.09.503414 — Posted: 2022-08-10
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps
Remesh, S. G., Merz, G. E., Britol, A. F., Chio, U. S., Rizo, A. N., Pospiech, T. H., Lui, I., Laurie, M. T., Glasgow, J., Le, C. Q., Zhang, Y., Diwanji, D., Hernandez, E., Lopez, J., Pawar, K. I., Pourmal, S., Smith, A. M., Zhou, F., QBI Coronavirus Research Group Structural Biology Consortium, , DeRisi, J., Kortemme, T., Rosenberg, O. S., Glasgow, A., Leung, K. K., Wells, J. A., Verba, K. A.
10.1101/2022.08.09.503400 — Posted: 2022-08-10
Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
Jian, F., Yu, Y., Song, W., Yisimayi, A., Yu, L., Gao, Y., Zhang, N., Wang, Y., Shao, F., Hao, X., Xu, Y., Jin, R., Wang, Y., Xie, X. S., Cao, Y.
10.1101/2022.08.09.503384 — Posted: 2022-08-10
SARS-CoV-2 genomic diversity in households highlights the challenges of sequence-based transmission inference
Bendall, E., Paz-Bailey, G., Santiago, G. A., Porucznik, C. A., Stanford, J. B., Stockwell, M. S., Duque, J., Jeddy, Z., Veguilla, V., Major, C., Rivera-Amill, V., Rolfes, M. A., Dawood, F. S., Lauring, A. S.
10.1101/2022.08.09.22278452 — Posted: 2022-08-10
SARS-CoV-2 viral clearance and viral load kinetics in young children (1-6 years) compared to adults: Results of a longitudinal study in Germany
Sandoni, A. E., Schaffrath Rosario, A., Michel, J., Kuttig, T., Wurm, J., Damerow, S., Iwanowski, H., Finkel, B., Schrick, L., Buchholz, U., Haas, W., Varnaccia, G., Kubisch, U., Jordan, S., Schienkiewitz, A., Nitsche, A., Loss, J.
10.1101/2022.08.09.22278540 — Posted: 2022-08-10
Efficacy and safety of convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized clinical trial
Lacombe, K., Hueso, T., Porcher, R., Mekinian, A., Chiarabini, T., Georgin-Lavialle, S., Ader, F., Saison, J., Martin-Blondet, G., De Castro, N. A., Bonnet, F., Cazanave, C., Francois, A., Morel, P., Hermine, O., Pourcher, V., Michel, M., Lescure, X., Soussi, N., Brun, P., Pommeret, F., Sellier, P., Rousset, S., Piroth, L., Michot, J.-M., baron, g., de Lamballerie, X., Mariette, X., Tharaux, P.-L., Resche-Rigaux, M., Ravaud, P., Simon, T., Tiberghien, P.
10.1101/2022.08.09.22278329 — Posted: 2022-08-10
Brief Report: Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine
Mwimanzi, F. M., Lapointe, H. R., Cheung, P. K., Sang, Y., Yaseen, F., Kalikawe, R., Datwani, S., Burns, L., Young, L., Leung, V., Ennis, S., Brumme, C. J., Montaner, J. S. G., Prystajecky, N., Lowe, C. F. J., DeMarco, M. L., Holmes, D. T., Simons, J., Niikura, M., Romney, M. G., Brumme, Z. L., Brockman, M. A.
10.1101/2022.08.08.22278494 — Posted: 2022-08-10
National Health Insurance Coverage and COVID-19 vaccine acceptance in Uganda. Implications on Uganda's achievement of Universal Healthcare Coverage and Sustainable Development Goals.
Kitara, D. L., Aloyo, J., Oyat, F. W. D., Obalim, L., Ikoona, E. N.
10.1101/2022.08.09.22278595 — Posted: 2022-08-10
Distinguishing features of Long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J., Lu, P., Dhodapkar, R. M., Gehlhausen, J. R., Tabachnikova, A., Tabacof, L., Malik, A. A., Kamath, K., Greene, K., Silva Monteiro, V., Pena-Hernandez, M., Mao, T., Bhattacharjee, B., Takahashi, T., Lucas, C., Silva, J., Mccarthy, D., Breyman, E., Tosto-Mancuso, J., Dai, Y., Perotti, E., Akduman, K., Tzeng, T., Xu, L., Yildirim, I., Krumholz, H. M., Shon, J., Medzhitov, R., Omer, S. B., van Dijk, D., Ring, A. M., Putrino, D., Iwasaki, A.
10.1101/2022.08.09.22278592 — Posted: 2022-08-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).